Clinical evaluation
Hypertension
BLOOD, DISEASE, DISEASE, HYPERTENSION
Demographic and clinical data (disease duration, disease activity, drug therapy, co-morbidities) were obtained through personal interview and medical records. Disease activity was determined by means of the Disease Activity Score-28 with C-reactive protein (DAS28-CRP) [Blood pressure (BP) was measured in two different days (visits 1 and 2), by an automated oscillometric device (Mindray MEC-1000, Shenzhen Mindray Bio-Medical Electronics Co, China) after 10-min seated rest, following the recommendations of the Brazilian Guidelines of Hypertension [Blood samples (30 ml) were collected after a 12-h overnight fast for characterization of the cardiometabolic profile of the participants. We assessed glucose, lipid profile (i.e., high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, very low-density lipoprotein (VLDL) cholesterol, total cholesterol, and triglycerides), C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR).